AR047749A1 - Composicion cristalina que contiene escitalopram - Google Patents
Composicion cristalina que contiene escitalopramInfo
- Publication number
- AR047749A1 AR047749A1 ARP050100683A ARP050100683A AR047749A1 AR 047749 A1 AR047749 A1 AR 047749A1 AR P050100683 A ARP050100683 A AR P050100683A AR P050100683 A ARP050100683 A AR P050100683A AR 047749 A1 AR047749 A1 AR 047749A1
- Authority
- AR
- Argentina
- Prior art keywords
- escitalopram
- particles
- composition containing
- crystal composition
- escitalopram oxalate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Partículas cristalinas de oxalato de escitalopram que tienen o bien una amplia distribucion de tamano de partícula o comprenden por lo menos 0,01 % (p/p) de Z-4-(4-dimetilamino-1-(4-fluorfenil)-but-1-enilo)-3-hidroxi-metil-benzonitrilo, donde dichas partículas son apropiadas para ser usadas en compresion directa. Forma de dosificacion farmacéutica unitaria que contiene dichas partículas cristalinas de oxalato de escitalopram así como también métodos de manufactura de dichas partículas de oxalato de escitalopram. Método para la reduccion de la cantidad de hidroxilo que contiene impurezas en una solucion de citalopram o escitalopram. Método de manufactura de partículas.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200400382 | 2004-03-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR047749A1 true AR047749A1 (es) | 2006-02-15 |
Family
ID=36607154
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP050100683A AR047749A1 (es) | 2004-03-05 | 2005-02-24 | Composicion cristalina que contiene escitalopram |
Country Status (9)
Country | Link |
---|---|
KR (1) | KR20060126587A (es) |
CN (3) | CN1925844A (es) |
AR (1) | AR047749A1 (es) |
IL (1) | IL177504A0 (es) |
MY (1) | MY142756A (es) |
PE (1) | PE20051162A1 (es) |
SG (1) | SG159504A1 (es) |
TW (1) | TW200605916A (es) |
ZA (1) | ZA200607382B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114763343A (zh) * | 2021-01-14 | 2022-07-19 | 浙江华海药业股份有限公司 | 一种西酞普兰或s-西酞普兰的纯化方法 |
CN113663356B (zh) * | 2021-08-23 | 2022-09-23 | 广西埃索凯新材料科技有限公司 | 一种应用于硫酸锰生产的结晶除杂监控系统 |
-
2005
- 2005-02-17 TW TW094104639A patent/TW200605916A/zh unknown
- 2005-02-21 SG SG201000567-6A patent/SG159504A1/en unknown
- 2005-02-21 ZA ZA200607382A patent/ZA200607382B/en unknown
- 2005-02-21 CN CNA2005800069400A patent/CN1925844A/zh active Pending
- 2005-02-21 KR KR1020067017907A patent/KR20060126587A/ko not_active Application Discontinuation
- 2005-02-21 CN CNA2009100028561A patent/CN101492436A/zh active Pending
- 2005-02-21 CN CNA2009100028557A patent/CN101492435A/zh active Pending
- 2005-02-24 AR ARP050100683A patent/AR047749A1/es not_active Application Discontinuation
- 2005-03-02 PE PE2005000241A patent/PE20051162A1/es not_active Application Discontinuation
- 2005-03-03 MY MYPI20050870A patent/MY142756A/en unknown
-
2006
- 2006-08-15 IL IL177504A patent/IL177504A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
PE20051162A1 (es) | 2006-01-16 |
KR20060126587A (ko) | 2006-12-07 |
ZA200607382B (en) | 2008-05-28 |
SG159504A1 (en) | 2010-03-30 |
IL177504A0 (en) | 2006-12-10 |
TW200605916A (en) | 2006-02-16 |
CN101492435A (zh) | 2009-07-29 |
CN1925844A (zh) | 2007-03-07 |
CN101492436A (zh) | 2009-07-29 |
MY142756A (en) | 2010-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0508769A (pt) | forma de dosagem resistente a adulteração compreendendo um adsorvente e um agente adverso | |
AR047988A1 (es) | Combinaciones antineoplásicas de cci-779 y rituximab | |
ATE530577T1 (de) | Epha2 agonistische monoklonale antikörper und deren anwendungsverfahren | |
EP2520311A3 (en) | Method of treating hemolytic disease | |
ATE314062T1 (de) | Zusammensetzungen zur abgabe von cortisolantagonisten | |
MA33044B1 (fr) | Composition pharmaceutique contenant des derives de glucopyranosyl diphenylmethane, sa forme posologique galenique, son procede de preparation et ses utilisations pour une regulation glycemique amelioree chez un patient | |
ES2523660T3 (es) | Composición para un material de electrodo, utilización de la misma y procedimiento para producir una célula solar | |
JP2005507881A5 (es) | ||
WO2007143607A3 (en) | Method of treating atrophic vaginitis | |
AR109263A2 (es) | Composición que comprende moxidectina | |
CY1111369T1 (el) | Φαρμακευτικη συνθεση που περιλαμβανει 3-(3-διμεθυλαμινο-1-αιθυλ-2-μεθυλ-προπυλ)-φαινολη και παρακεταμολη | |
MX2010002926A (es) | Moduladores de tieno y furo-pirimidina del receptor h4 de histamina. | |
WO2005023193A3 (en) | Methods of treating endometriosis | |
TW200501965A (en) | Highly pure fondaparinux sodium composition,process for preparing said composition and pharmaceutical compositions containing it as active principle | |
WO2005051307A3 (en) | Epha2 agonistic monoclonal antibodies and methods of use thereof | |
SE0200895D0 (sv) | New pharmaceutical composition | |
BR0307518A (pt) | Composição farmacêutica | |
EA201070806A1 (ru) | Состав медленного высвобождения на основе ассоциации гликогена и альгината | |
AR047749A1 (es) | Composicion cristalina que contiene escitalopram | |
WO2006048261A3 (en) | Oral solid dosage forms containing a low dose of estradiol | |
BRPI0415571A (pt) | composições de limpeza | |
NO20064499L (no) | Krystallinsk sammensetning inneholdende escitalopram-oksalat | |
NZ593217A (en) | Extrudate having spicular active substances | |
UY28789A1 (es) | Composición cristalina que contiene escitalopram | |
SE0000303D0 (sv) | Novel compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |